Visitar URL original
Structural and Congenital Heart Disease | An Open Access Journal from Tech Science Press

SCHD Open Access

Structural and Congenital Heart Disease

ISSN:3071-1738 (online)
Publication Frequency:Bi-monthly

  • Online
    Articles

    1828

  • on board
    editors

    104

Special Issues





About the Journal

Structural and Congenital Heart Disease (formerly known as Congenital Heart Disease) is a peer-reviewed journal dedicated to the study and management of heart disease across the lifespan. The journal covers both congenital and structural heart diseases, reflecting the evolving landscape of cardiovascular research and clinical practice.
As the official journal of the Children’s Hospital of Nanjing Medical University, it is committed to publishing high-quality clinical studies, invited editorials, state-of-the-art reviews, case reports, articles addressing the history and development of heart disease, and continuing medical education (CME) materials.
All manuscripts, including invited submissions, undergo a rigorous and thorough editorial and peer-review process to ensure the reliability, scientific integrity, and clinical relevance of published research.

Indexing and Abstracting

Formerly Congenital Heart Disease[Science Citation Index Expanded (Clarivate Analytics): 2025 Impact Factor: 2.3; Scopus CiteScore (Impact per Publication 2025): 1.9; SNIP (Source Normalized Impact per Paper 2025): 0.461; Journal Citation Report/Science Edition (JCR); etc.]

Effective with Volume 21, Issue 1 (2026), Congenital Heart Disease was renamed Structural and Congenital Heart Disease.
The journal remains dedicated to high-quality research in congenital and structural heart diseases and continues under the same editorial leadership and peer-review framework.
Read the formal announcement from the Editors-in-Chief, here.

  • Open Access

    REVIEW

    The International Quality Improvement Collaborative for Congenital Heart Disease: Registry Development, Long-Term Trends, and Current Surgical Outcomes in Low- and Middle-Income Countries

    Hannah Paige Rogers1, Kimberlee Gauvreau1, Anna Fisk1, Babar Hasan2, Patricia Hickey1, Raman Krishna Kumar3, William Novick4,5, Nestor Sandoval6, Bistra Zheleva7, Kathy J. Jenkins1,*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.085936 - 30 September 2026
    (This article belongs to the Special Issue: Registries in Congenital Heart Disease)
    Abstract Background: Congenital heart disease (CHD) remains the most common birth defect worldwide, with nearly one-quarter of affected infants requiring intervention in the first year of life. Despite global reductions in childhood mortality, 90% of children born with CHD in low- and middle-income countries (LMICs) lack access to essential cardiac care, contributing to significantly higher morbidity and mortality from CHD compared to high-income countries. The International Quality Improvement Collaborative for Congenital Heart Disease: Improving Care for Low- and Middle-Income Countries (IQIC) was established in 2008 to address these gaps by supporting LMIC cardiac centers through standardized surgical… More >

  • Open Access

    ARTICLE

    Long-Term Survival Following the Fontan Procedure: A Focus on Hepatic Function in a Twenty-Year Single-Center Cohort from Southern China

    Xiang Liu1,2,#, Linjiang Han1,2,#, Zirui Huang1,2, Jiazichao Tu1,2, Ruyue Zhang1,2, Jimei Chen1,2,*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.083722 - 30 September 2026
    Abstract Background: This study aimed to evaluate the long-term prognosis and influencing factors in patients who underwent Fontan palliation. We specifically investigated the impact of demographic characteristics, preoperative clinical conditions, surgical techniques, and postoperative variables-particularly liver dysfunction markers such as the Model for End-Stage Liver Disease excluding the international normalized ratio (MELD-XI) score-on survival outcomes. Methods: We conducted a retrospective cohort study involving 322 patients who underwent the Fontan procedure. Comprehensive data on demographics, perioperative parameters, and long-term outcomes were collected. Kaplan-Meier survival analysis was performed to estimate 1-, 5-, 10-, and 15-year survival rates, with subgroup… More >

  • Open Access

    ARTICLE

    Procedural Performance and Safety of VACS® Balloon Catheters in Congenital Heart Interventions

    Guido Mandilaras1,2,*, Anja Tengler1, Andre Jakob1, Robert Dalla Pozza1, Nikolaus A. Haas1

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.080384 - 30 September 2026
    Abstract Background: Balloon catheters are essential tools in congenital cardiac catheterization and are used for therapeutic balloon dilatation, anatomical balloon interrogation, and stent implantation. Clinical performance data for established devices have become increasingly important under the European Medical Device Regulation (MDR). We evaluated the procedural performance and safety of the Osypka VACS® (Valvuloplasty Catheter System; Osypka AG, Rheinfelden, Germany) II and VACS® III balloon catheters across a broad spectrum of congenital heart interventions. Methods: This retrospective single-center study reviewed the institutional experience with VACS® II and VACS® III balloon catheters over 10 years. Consecutive procedures from predefined indication groups… More >

  • Open Access

    ARTICLE

    Early to Mid-Term Cardiac Magnetic Resonance Findings after Transcatheter Pulmonary Valve Replacement in Patients with Repaired Tetralogy of Fallot

    Meryem Beyazal*, Merter Keceli, Emine Gulsah Torun, Ibrahim Ece

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.080538 - 30 September 2026
    Abstract Background: Cardiac magnetic resonance (CMR) imaging following transcatheter pulmonary valve replacement (TPVR) allows for the assessment of right ventricular (RV) volume. This study aimed to evaluate early- to mid-term findings after the procedure. Methods: A total of 21 patients with repaired tetralogy of Fallot who underwent TPVR were enrolled in the study. CMR data before and after the procedure were compared. The median interval between the procedure and the post-TPVR CMR was 9 months (range: 6–18 months). Results: RV volumes and RV end-diastolic volume indices were significantly lower after TPVR compared to before the procedure. RV volume… More >

  • Open Access

    CASE REPORT

    Acute Hypoattenuating Leaflet Thickening after Percutaneous Pulmonary Valve Implantation: A Case Report

    Yee-Tat Lee1,2, Hay-Son Robin Chen3, Ka-Lam Calvin Leung1,2, Chun-Ka Wong1,2, Ho-On Alston Chiu1,2, Chi-Wai Stephen Cheung4, Yuen-Hei Mak4, Ka-Chun Un1,2,*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.078486 - 30 September 2026
    Abstract Background: Hypoattenuating leaflet thickening (HALT) is a reported complication following percutaneous pulmonary valve implantation (PPVI) Case description: A 32-year-old man with a history of repaired Tetralogy of Fallot (TOF) underwent PPVI for symptomatic severe pulmonary regurgitation (PR). The postoperative course was complicated by HALT diagnosed by computed tomography (CT) within 24 h of the procedure. Anticoagulation therapy was administered, and reassessment CT at 4 months showed resolution of HALT. Conclusion: HALT following PPVI is managed with anticoagulation yet consensus for optimal management strategy is lacking. More >

  • Open Access

    ARTICLE

    Isolated Closure versus Mitral Valvuloplasty for Patent Ductus Arteriosus in Patients with Mitral Regurgitation: A Single-Center, Retrospective Study

    Jiaqing Tang1,2, Yushen Fang1,2, Jiahong Li2,3, Zechen Li1,2, Zhuyang Yang2,3, Huiru Xie2,4, Miao Tian1,2,3, Zhanhao Su1,2,3, Shusheng Wen1,2,3, Xiaohua Li1,2,3,*, Haiyun Yuan1,2,3,4,*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.080591 - 30 September 2026
    Abstract Background: Patent ductus arteriosus (PDA) can cause left-heart volume overload and functional mitral regurgitation (MR), although some patients have structural mitral abnormalities requiring repair. We compared MR and cardiac remodeling after isolated PDA closure and PDA closure combined with mitral valvuloplasty (MVP). Methods: This single-center retrospective study included 68 children treated between February 2013 and February 2025: isolated PDA transcatheter occlusion (IPTO, n = 34), isolated PDA surgical ligation (IPSL, n = 20), and PDA ligation with concomitant mitral valvuloplasty (PLMVP, n = 14). Body-size-adjusted cardiac dimensions were analyzed at baseline and discharge, while MR outcomes… More >

  • Open Access

    ARTICLE

    Chronic Fatigue in Adolescents: The Role of Congenital Heart Disease vs. Psychosocial Factors

    Elena Likhomanova1, Olga Shevaldova1,2,*, Anastasia Kovaleva1, Anna Zavarina2

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.079461 - 30 September 2026
    (This article belongs to the Special Issue: Mental Health & Behaviour in CHD)
    Abstract Background: Fatigue is a prevalent clinical complaint in adolescence, but its determinants—particularly in congenital heart disease (CHD)—remain poorly understood. Objective: This study aimed to compare the severity and multidimensional profile of fatigue symptoms between adolescents with corrected CHD and school-based peers without reported chronic disease, and to evaluate the independent contributions of cardiac severity indices, echocardiographic parameters, and physical work capacity to fatigue severity. Methods: In a cross-sectional comparative study, 229 adolescents (11–17 years), including 154 with corrected CHD (simple, moderate, complex defects) and 75 controls, completed the validated Russian “Degree of Chronic Fatigue” questionnaire. All CHD… More >

  • Open Access

    ARTICLE

    Investigation into the Intelligent Recognition of Common Congenital Heart Disease Based on Echocardiography

    Yanan Pan1,2, Weize Xu2,3,4,*, Zhiwei Zhang4, Mengmeng Su4, Xiaohua Pan4, Jingjing Ye1,2,4, Jin Yu1,2,4,*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.079240 - 30 September 2026
    Abstract Background: Congenital heart disease (CHD) is characterized by a high incidence and low detection rate. The shortage of pediatric echocardiologists limits the routine ultrasound screening for CHD in many institutions. Deep learning has emerged as a promising tool to enhance the CHD diagnosis. This study aims to develop and evaluate a two-branch, two-stage intelligent algorithm (OBICnet) based on echocardiographic images to predict and classify common CHD in pediatric patients. Methods: A total of 8543 static color Doppler images from 3134 children were analyzed, with each child contributing 1 to 7 standard sectional views. The dataset was… More >

  • Open Access

    ARTICLE

    Risk Factors of Decreased Abdominal Tissue Oxygen Saturation in Infants with Congenital Heart Disease after Cardiac Surgery

    Dan Li, Rongyuan Zhang, Yuzi Zhou, Yazhou Jiang, Xu Wang, Xia Li*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.081407 - 30 September 2026
    Abstract Background: Infants undergoing surgery for congenital heart disease (CHD) are at high risk of developing gastrointestinal dysfunction (GID). Although abdominal near-infrared spectroscopy (NIRS) for monitoring tissue oxygen saturation (StO2) has shown clinical promise, its prognostic value remains to be fully elucidated. This study aimed to identify the risk factors associated with postoperative declines in abdominal StO2 and to evaluate its correlation with clinical outcomes. Methods: A total of 439 infants undergoing cardiac surgery with cardiopulmonary bypass between January 2024 and January 2025 were retrospectively enrolled. Continuous postoperative NIRS monitoring was performed during the first 72 h of… More >

  • Open Access

    REVIEW

    Patent Foramen Ovale in Cryptogenic Stroke: A 20-Year Systematic Review of Evolving Interventional and Antithrombotic Strategies

    Li Wang#, Hongzhao Li#, Ling Liu, Yanchao Qi, Dahong Zhang, Yanchun Zhi, Runyu Wang, Gairong Jin, Shunda Liu, Huilian Tan*, Jun Liu*

    Structural and Congenital Heart Disease, Vol.21, No.4, 2026, DOI:10.32604/schd.2026.084716 - 30 September 2026
    Abstract Background: Patent foramen ovale (PFO) is the most prevalent congenital cardiac anomaly and a key structural heart disease enabling paradoxical embolism, a leading mechanism of cryptogenic stroke. Over the past two decades, the management of PFO-associated stroke has evolved substantially from antithrombotic therapy alone to include percutaneous PFO closure. This systematic review aims to delineate the evolution of therapeutic strategies and clinical evidence in PFO-related stroke research, with particular emphasis on interventional and antithrombotic approaches. Methods: We performed a preferred reporting items for systematic reviews and meta-Analyses (PRISMA)-informed bibliometric systematic review of literature published from 2004… More >

    Graphic Abstract

    Patent Foramen Ovale in Cryptogenic Stroke: A 20-Year Systematic Review of Evolving Interventional and Antithrombotic Strategies

Copyright © 2026 The Author(s). Published by Tech Science Press.

Share Link